3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
4MXX_DB8_Q6PLK2.pdb,DB8,4MXX,Q6PLK2,266,446,90,0.695,0.338,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,protein kinase B-like protein [Plasmodium falciparum],256,-7.912
3UE4_DB8_Q6PLK2.pdb,DB8,3UE4,Q6PLK2,270,446,96,0.678,0.356,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,protein kinase B-like protein [Plasmodium falciparum],240,-7.963
3SOA_DB8_O15865.pdb,DB8,3SOA,O15865,436,513,126,0.609,0.289,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,CDPK2 [Plasmodium falciparum],301,-8.406
4MXZ_DB8_O15865.pdb,DB8,4MXZ,O15865,266,513,81,0.692,0.305,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,CDPK2 [Plasmodium falciparum],216,-8.049
4MXO_DB8_O15865.pdb,DB8,4MXO,O15865,266,513,80,0.64,0.301,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,CDPK2 [Plasmodium falciparum],217,-7.749
4QMN_DB8_O77239.pdb,DB8,4QMN,O77239,284,305,115,0.637,0.405,Tocris,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,Uniprot,5328940,A,cdk-related protein kinase 6 [Plasmodium falciparum],286,-8.88
